Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bigot

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Revue De Pneumologie Clinique|February 26, 2014
[Therapeutic impact of molecular diagnosis in metastatic non-small cell lung cancer: targeted therapies in 2013]N Pecuchet, F Bigot, M Henni, et al.
Soins. Psychiatrie|November 1, 1993
[Educating for community practice]F Bigot, C Caron, S Hocher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2013
Triple combination of bevacizumab, gemcitabine and platinum salt in metastatic collecting duct carcinomaN Pécuchet, F Bigot, J Gachet, et al.
ESMO Open|July 24, 2025
Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysisK Amrane, B Cabarrou, G Justeau, et al.
ESMO Open|December 30, 2025
HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomasD M Filippini, B Cabarrou, C Dupain, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Revue De Pneumologie Clinique|February 26, 2014
[Therapeutic impact of molecular diagnosis in metastatic non-small cell lung cancer: targeted therapies in 2013]N Pecuchet, F Bigot, M Henni, et al.
Soins. Psychiatrie|November 1, 1993
[Educating for community practice]F Bigot, C Caron, S Hocher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2013
Triple combination of bevacizumab, gemcitabine and platinum salt in metastatic collecting duct carcinomaN Pécuchet, F Bigot, J Gachet, et al.
ESMO Open|July 24, 2025
Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysisK Amrane, B Cabarrou, G Justeau, et al.
ESMO Open|December 30, 2025
HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomasD M Filippini, B Cabarrou, C Dupain, et al.
Pageof 1